Brandon Wilder, Ph.D.

  • Associate Professor, VGTI-Vaccine and Gene Therapy Institute
  • M.D./Ph.D. Program Committee, School of Medicine

Biography

Brandon Wilder attended the University of Florida where he received his B.S. in 2006 and his Ph.D. in Immunology and Microbiology in 2012. He then did his postdoctoral fellowship with Stefan Kappe at the Center for Infectious Disease Research in Seattle, WA where he studied protective immune responses to malaria and eventually finished as a Research Assistant Professor in 2018. He then joined the OHSU Vaccine and Gene Therapy Institute in as an Assistant Professor where he remains. From 2019-2023, he also split his time serving as the Unit Head of Immunology and Vaccine Development in the Department of Parasitology at the Naval Medical Research Unit-SOUTH in Lima, Peru.

Education and training

  • Degrees

    • B.S., 2006, University of Florida
    • Ph.D., 2012, University of Florida

Publications

Elsevier pure profile

Selected publications

  • Julio Ventocilla, L. Lorena Tapia, Lisa Sperling, Reynaldo Ponce, Adriano Franco, Mindy Leelawong, Joao C. Aguiar, G. Christian Baldeviano, Brandon K. Wilder. Analysis of Pre-Erythrocytic Immunity During Plasmodium Vivax Infection Reveals a Diversity of Responses That is Partially Due to Blood Stage Cross-Reactivity, 25 May 2021, PREPRINT available at Research Square.
  • MacMillen Z, Hatzakis K, Simpson A, Shears MJ, Watson F, Erasmus JH, Khandhar AP, Wilder B, Murphy SC, Reed SG, Davie JW, Avril M. Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine. NPJ Vaccines. 2024 Jan 10;9(1):12. doi: 10.1038/s41541-023-00799-4. PubMed PMID: 38200025
  • Wilder BK, Vigdorovich V, Carbonetti S, Minkah N, Hertoghs N, Raappana A, Cardamone H, Oliver BG, Trakhimets O, Kumar S, Dambrauskas N, Arredondo SA, Camargo N, Seilie AM, Murphy SC, Kappe SHI, Sather DN. Anti-TRAP/SSP2 monoclonal antibodies can inhibit sporozoite infection and may enhance protection of anti-CSP monoclonal antibodies. NPJ Vaccines. 2022 May 26;7(1):58. doi: 10.1038/s41541-022-00480-2. PubMed PMID: 35618791
  • Aleshnick M, Florez-Cuadros M, Martinson T, Wilder BK. Monoclonal antibodies for malaria prevention. Mol Ther. 2022 May 4;30(5):1810-1821. doi: 10.1016/j.ymthe.2022.04.001. Epub 2022 Apr 5. Review. PubMed PMID: 35395399
  • Minkah NK, Wilder BK, Sheikh AA, Martinson T, Wegmair L, Vaughan AM, Kappe SHI. Innate immunity limits protective adaptive immune responses against pre-erythrocytic malaria parasites. Nat Commun. 2019 Sep 2;10(1):3950. doi: 10.1038/s41467-019-11819-0. PubMed PMID: 31477704